NVLX The PCRT, an affiliate of TD2, has the explicit mission to organize and accelerate the clinical development of new agents for the treatment of patients with pancreatic cancer. http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
(0)
(0)
PharmaCyte Biotech Inc. (PMCB) Stock Research Links